Home » Topics » BioWorld Science

BioWorld Science
RSS

Alkermes, Clovis Oncology enter collaboration to explore combination cancer therapies

Feb. 21, 2019

KEYNOTE-240 trial of Keytruda in previously treated HCC does not meet primary endpoint

Feb. 21, 2019

Faron reports early observations on first patients in MATINS study of Clevegen

Feb. 21, 2019

Mustang and National Children's Hospital partner to develop C-134 for GBM

Feb. 21, 2019

Study evaluates nitisinone for 1 year in patients with oculocutaneous albinism

Feb. 21, 2019

FDA clears IND for phase I study of KT-1002 for IBD

Feb. 21, 2019

New phase I study explores use of cardiac troponin activator AMG-594 in healthy subjects

Feb. 21, 2019

Pluristem, NASA enter collaboration to study PLX cell therapies in space missions

Feb. 21, 2019

Antitumor agent Temodal obtains additional indication approval for Ewing's sarcoma in Japan

Feb. 21, 2019

January Therapeutics synthesizes gemcitabine prodrugs

Feb. 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...